PAS
ZLAB icon

Park Avenue Securities’s Zai Lab ZLAB Stock Holding History

Park Avenue Securities’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,615
Closed -$224K – 1712
2025
Q3 		$224K Buy
6,615
+40
+0.6% +$1.38K ﹤0.01% 1527
2025
Q2 		$230K Buy
+6,575
New +$216K ﹤0.01% 1387

Other funds holding ZLAB

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Park Avenue Securities's ZLAB Position: Q4 2025 in Review

Park Avenue Securities sold out of Zai Lab (ZLAB) in Q4 2025, closing a stake of 6,615 shares — an estimated $224K sold.

Park Avenue Securities first reported a position in ZLAB in Q2 2025 and held it in 2 quarters. The position peaked at $230K in Q2 2025. 126 funds tracked by Wall St. Rank hold ZLAB as of Q4 2025.

  • Park Avenue Securities reported no remaining Zai Lab position as of Q4 2025 after selling out during the quarter.
  • Park Avenue Securities sold 6,615 Zai Lab shares in Q4 2025, an estimated $224K.
  • Park Avenue Securities first reported a position in Zai Lab in Q2 2025 and held it in 2 quarters.
  • Park Avenue Securities's Zai Lab position peaked at $230K in Q2 2025.
  • 126 funds tracked by Wall St. Rank held Zai Lab as of Q4 2025.

Based on Park Avenue Securities's 13F filing for Q4 2025, filed 5 Jan 2026.